France· FR:66610933
XELJANZ 11 mg, comprimé à libération prolongée
A medicinal product containing citrate de tofacitinib, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CITRATE DE TOFACITINIB
- Manufacturer
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930199893plaquette(s) aluminium PVC-Aluminium de 28 comprimésEUR 634.25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Citrate de tofacitinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTofacitinibAjanta Pharma USA Inc.
- CzechiaXELJANZPfizer Europe MA EEIG, Bruxelles
- NorwayXeljanzPfizer
- CanadaTARO-TOFACITINIB XRTARO PHARMACEUTICALS INC
- FinlandXeljanzParanova Oy
- NetherlandsXeljanz 11 mg, tablet met verlengde afgiftePfizer Europe MA EEIG
- PolandXeljanzPfizer Europe MA EEIG
- SwedenXELJANZ 11 mg DepottablettPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Tofacitinib Devatis, Tofacitinib Stada
- Bulgaria · Tофацитиниб Devatis
- Denmark · Tofacitinib Accord, Tofacitinib Newbury
- Spain · Tofacitinib Stada
- Finland · Tofacitinib Devatis, Tofacitinib Stada
- United Kingdom (Northern Ireland) · Tofacitinib Amarox, Tofacitinib Brown & Burk Uk
- Croatia · Tofacitinib Accord, Tofacitinib Stada
- Iceland · Xeljanz
- Liechtenstein · Xeljanz
- Malta · Tofacitinib Stada
- Netherlands · Tofacitinib Devatis, Tofacitinib Stada
- Norway · Tofacitinib Accord, Tofacitinib Devatis
- Portugal · Tofacitinib Bluepharma
- Sweden · Tofacitinib Devatis, Tofacitinib Newbury
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff5ae20d-f58b-4480-a27f-768cd9989f98 GET /v1/drugs/ff5ae20d-f58b-4480-a27f-768cd9989f98?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66610933",
"date_amm": "2019-12-16",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/17/1178",
"substance": "CITRATE DE TOFACITINIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about citrate de tofacitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.